Guangdie Yang

580 total citations
20 papers, 446 citations indexed

About

Guangdie Yang is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Guangdie Yang has authored 20 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Guangdie Yang's work include Lung Cancer Research Studies (3 papers), Immune Response and Inflammation (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Guangdie Yang is often cited by papers focused on Lung Cancer Research Studies (3 papers), Immune Response and Inflammation (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Guangdie Yang collaborates with scholars based in China, Italy and Japan. Guangdie Yang's co-authors include Jianying Zhou, Yinan Yao, Guohua Lu, Zhang Bao, Junjun Chen, Jianya Zhou, Fenlai Tan, Qiong Zhao, Nong Xu and Yingxiang Wang and has published in prestigious journals such as PLoS ONE, Oncotarget and Journal of Cellular and Molecular Medicine.

In The Last Decade

Guangdie Yang

19 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guangdie Yang China 14 170 160 133 125 65 20 446
Linglong Peng China 7 257 1.5× 132 0.8× 85 0.6× 120 1.0× 118 1.8× 7 477
Renyu Lin China 10 252 1.5× 102 0.6× 56 0.4× 185 1.5× 147 2.3× 18 466
Hanju Hua China 10 231 1.4× 265 1.7× 167 1.3× 50 0.4× 53 0.8× 20 497
Dominic Denk Germany 5 199 1.2× 155 1.0× 123 0.9× 142 1.1× 125 1.9× 7 460
Ali Adili Iran 11 209 1.2× 260 1.6× 164 1.2× 86 0.7× 101 1.6× 29 563
Xiaobin Ma China 12 155 0.9× 60 0.4× 55 0.4× 52 0.4× 57 0.9× 31 378
Seyedeh Golsar Mirabolfathinejad United States 4 164 1.0× 275 1.7× 284 2.1× 116 0.9× 68 1.0× 4 561
I‐Che Chung Taiwan 12 393 2.3× 62 0.4× 125 0.9× 48 0.4× 125 1.9× 17 512
Hitendra S. Solanki United States 13 266 1.6× 80 0.5× 61 0.5× 51 0.4× 103 1.6× 26 478
Yun Liao China 12 232 1.4× 107 0.7× 165 1.2× 67 0.5× 62 1.0× 18 508

Countries citing papers authored by Guangdie Yang

Since Specialization
Citations

This map shows the geographic impact of Guangdie Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangdie Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangdie Yang more than expected).

Fields of papers citing papers by Guangdie Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangdie Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangdie Yang. The network helps show where Guangdie Yang may publish in the future.

Co-authorship network of co-authors of Guangdie Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Guangdie Yang. A scholar is included among the top collaborators of Guangdie Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangdie Yang. Guangdie Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Xu, Fei, Zhu Zeng, Bing Yan, et al.. (2021). Safety and efficacy of anti-PD-1 inhibitors in Chinese patients with advanced lung cancer and hepatitis B virus infection: a retrospective single-center study. Translational Lung Cancer Research. 10(4). 1819–1828. 8 indexed citations
4.
Yang, Guangdie, Jie Wang, Yinan Yao, et al.. (2021). Peripheral Lung Squamous Carcinoma With ROS1 Rearrangement Sensitive to Crizotinib: A Case Report. Frontiers in Oncology. 11. 703318–703318. 1 indexed citations
5.
Yang, Guangdie, Yinan Yao, Guohua Lu, et al.. (2020). Dioscin elicits anti‐tumour immunity by inhibiting macrophage M2 polarization via JNK and STAT3 pathways in lung cancer. Journal of Cellular and Molecular Medicine. 24(16). 9217–9230. 61 indexed citations
6.
Yang, Guangdie, et al.. (2020). Possible environmental exposure-associated pulmonary cryptococcosis in a patient with rheumatoid arthritis: a case report and literature review. Journal of International Medical Research. 48(10). 1220761854–1220761854.
7.
Yao, Yinan, Guangdie Yang, Guohua Lu, et al.. (2020). Dioscin facilitates ROS-induced apoptosis via the p38-MAPK/HSP27-mediated pathways in lung squamous cell carcinoma. International Journal of Biological Sciences. 16(15). 2883–2894. 39 indexed citations
8.
Yao, Yinan, et al.. (2020). CircRNA0001859, a new diagnostic and prognostic biomarkers for COPD and AECOPD. BMC Pulmonary Medicine. 20(1). 311–311. 20 indexed citations
9.
Lu, Shan, Yinan Yao, Junjun Chen, et al.. (2020). Downregulation of hsa_circ_0007580 inhibits non-small cell lung cancer tumorigenesis by reducing miR-545-3p sponging. Aging. 12(14). 14329–14340. 21 indexed citations
10.
Lou, Bin, Guangdie Yang, Chuangen Guo, et al.. (2019). Role of <b><i>Aspergillus fumigatus-</i></b>Specific IgE in the Diagnosis of Allergic Bronchopulmonary Aspergillosis. International Archives of Allergy and Immunology. 178(4). 338–344. 13 indexed citations
11.
Yao, Yinan, et al.. (2018). Honokiol induces apoptosis of lung squamous cell carcinoma by targeting FGF2‐FGFR1 autocrine loop. Cancer Medicine. 7(12). 6205–6218. 16 indexed citations
12.
Bao, Zhang, Pei Zhang, Yinan Yao, et al.. (2017). Deguelin Attenuates Allergic Airway Inflammation via Inhibition of NF-κb Pathway in Mice. International Journal of Biological Sciences. 13(4). 492–504. 24 indexed citations
13.
Bao, Zhang, Guohua Lu, Dawei Cui, et al.. (2016). IL-17A-producing T cells are associated with the progression of lung adenocarcinoma. Oncology Reports. 36(2). 641–650. 24 indexed citations
14.
Yao, Yinan, Junjun Chen, Weiyi Xu, et al.. (2016). TREM-2 serves as a negative immune regulator through Syk pathway in an IL-10 dependent manner in lung cancer. Oncotarget. 7(20). 29620–29634. 40 indexed citations
15.
Gao, Xuan, Junjun Chen, Guangdie Yang, et al.. (2015). Interleukin-10 Promoter Gene Polymorphisms and Susceptibility to Tuberculosis: A Meta-Analysis. PLoS ONE. 10(6). e0127496–e0127496. 19 indexed citations
16.
Zhang, Xiang, Guangdie Yang, Ying Zhang, et al.. (2014). An experimental research into endostatin microbubble combined with focused ultrasound for anti-tumor angiogenesis in colon cancer. Gastroenterology report. 2(1). 44–53. 8 indexed citations
17.
Yang, Guangdie, Hequan Li, Yinan Yao, et al.. (2014). Treg/Th17 imbalance in malignant pleural effusion partially predicts poor prognosis. Oncology Reports. 33(1). 478–484. 23 indexed citations
18.
Yang, Guangdie, Junjun Chen, Fei Xu, et al.. (2014). Association between Tumor Necrosis Factor-α rs1800629 Polymorphism and Risk of Asthma: A Meta-Analysis. PLoS ONE. 9(6). e99962–e99962. 16 indexed citations
19.
Zhao, Qiong, Jianzhong Shentu, Nong Xu, et al.. (2010). Phase I study of icotinib hydrochloride (BPI-2009H), an oral EGFR tyrosine kinase inhibitor, in patients with advanced NSCLC and other solid tumors. Lung Cancer. 73(2). 195–202. 81 indexed citations
20.
Zhou, Jianying, et al.. (2009). Activated changes of platelet ultra microstructure and plasma granule membrane protein 140 in patients with non-small cell lung cancer.. PubMed. 122(9). 1026–31. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linglong Peng Breakdown of academic impact, for papers by Renyu Lin Breakdown of academic impact, for papers by Hanju Hua Breakdown of academic impact, for papers by Dominic Denk Breakdown of academic impact, for papers by Ali Adili Breakdown of academic impact, for papers by Xiaobin Ma Breakdown of academic impact, for papers by Seyedeh Golsar Mirabolfathinejad Breakdown of academic impact, for papers by I‐Che Chung Breakdown of academic impact, for papers by Hitendra S. Solanki Breakdown of academic impact, for papers by Yun Liao
Rankless by CCL
2026